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1. INTRODUCTION {#myc13064-sec-0006}
===============

Invasive aspergillosis due to azole‐resistant *A fumigatus* has become a major medical concern associated with high mortality in immunocompromised individuals.[1](#myc13064-bib-0001){ref-type="ref"}, [2](#myc13064-bib-0002){ref-type="ref"}, [3](#myc13064-bib-0003){ref-type="ref"} Azole resistance in *A fumigatus* emerges due to long‐term treatment with azole antifungals, but also extensive exposure of the fungus to azole compounds in the environment is a major driver of resistance selection.[4](#myc13064-bib-0004){ref-type="ref"}, [5](#myc13064-bib-0005){ref-type="ref"}, [6](#myc13064-bib-0006){ref-type="ref"}, [7](#myc13064-bib-0007){ref-type="ref"} Resistance to azole drugs in *A fumigatus* is mainly linked to multiple amino acid substitutions in the *cyp*51A gene. The most described *cyp51A*‐mediated resistance mechanism is a 34‐basepair (bp) sequence tandem repeat (TR~34~) in the promoter region of *cyp51A* gene combination with the L98H substitution followed by a double substitution combined with a 46 bp tandem duplication in the *cyp51A* promoter (TR~46~/Y121F/T289A).[8](#myc13064-bib-0008){ref-type="ref"}, [9](#myc13064-bib-0009){ref-type="ref"} These mutations lead to high‐level resistance to triazole antifungals of *A fumigatus* isolates from both azole‐naive and azole‐treated patients.[10](#myc13064-bib-0010){ref-type="ref"} Furthermore, several institutions report a rise in resistant strains found in environmental niches such as soil samples, paddy fields, aerial samples of hospitals and compost.[11](#myc13064-bib-0011){ref-type="ref"}, [12](#myc13064-bib-0012){ref-type="ref"}, [13](#myc13064-bib-0013){ref-type="ref"}, [14](#myc13064-bib-0014){ref-type="ref"}, [15](#myc13064-bib-0015){ref-type="ref"}, [16](#myc13064-bib-0016){ref-type="ref"}, [17](#myc13064-bib-0017){ref-type="ref"}, [18](#myc13064-bib-0018){ref-type="ref"}, [19](#myc13064-bib-0019){ref-type="ref"} Compost (decaying plant waste material) is an important source of *A fumigatus*. It is known that high concentrations of azole‐resistant *A fumigatus* spores are released during incomplete composting processes, especially when azole residues from agricultural waste are present.[11](#myc13064-bib-0011){ref-type="ref"}, [13](#myc13064-bib-0013){ref-type="ref"}, [14](#myc13064-bib-0014){ref-type="ref"}, [15](#myc13064-bib-0015){ref-type="ref"}, [20](#myc13064-bib-0020){ref-type="ref"}, [21](#myc13064-bib-0021){ref-type="ref"}, [22](#myc13064-bib-0022){ref-type="ref"}, [23](#myc13064-bib-0023){ref-type="ref"} Azole‐resistant *A fumigatus* with the TR~34~/L98H mutation in the environment has been reported earlier in Iran.[24](#myc13064-bib-0024){ref-type="ref"} Here, we report for the first time the presence of resistance due to the TR~46~/Y121F/T289A mutation.

2. MATERIAL AND METHODS {#myc13064-sec-0007}
=======================

2.1. Sample collection and identification of azole resistent *A fumigatus* isolates {#myc13064-sec-0008}
-----------------------------------------------------------------------------------

Three hundred compost samples from different regions of Iran (Mazandaran province (n = 200) and Tehran province (n = 100), located about 300 km apart, were collected during 2017‐2018. To recover *A* *fumigatus* strains, 1 cm^2^ compost was dissolved in 5 mL sterile saline solution containing Tween 40 (0.05%), vortexed, and allowed to settle. Briefly, according to a previously described protocol, for primary screening of azole‐resistant *A fumigatus* strains from the supernatant, 100 μL was plated on a Sabouraud dextrose agar plate (SDA; Difco), supplemented with 4 and 1 mg/L itraconazole and voriconazole, respectively, and incubated at 45°C for 72 hours in the dark.[23](#myc13064-bib-0023){ref-type="ref"} Identification of *Aspergillus* section Fumigati was performed based on both macroscopic and microscopic characteristics. Subsequently, molecular identification with DNA sequencing of the partial b‐tubulin gene, using TUB2a (5‐ TGACCCAGCAGATGTT‐3) and TUB2b (5‐GTTGTTGGGAATCCACTC‐3), was done.[25](#myc13064-bib-0025){ref-type="ref"}

2.2. In vitro antifungal susceptibility testing {#myc13064-sec-0009}
-----------------------------------------------

To detect azole‐resistant *A fumigatus*, colonies that grew on screening media supplemented with itraconazole and voriconazole and confirmed by DNA sequencing as *A fumigatus* were selected and evaluated with microbroth dilution minimum inhibitory concentration (MIC) testing using the Clinical and Laboratory Standards Institute document for filamentous fungi.[26](#myc13064-bib-0026){ref-type="ref"} *Paecilomyces variotii* (ATCC 22319) and *Candida parapsilosis* (ATCC 22019) were used as quality controls.

2.3. Detection of *cyp51A* gene mutations {#myc13064-sec-0010}
-----------------------------------------

Isolates with reduced susceptibility to voriconazole (MIC \>2 µg/mL) were tested with a mixed‐format real‐time PCR assay as described before.[27](#myc13064-bib-0027){ref-type="ref"} Isolates with TR~46~/Y121F/T289A mutations were further confirmed by sequencing the cyp51A gene as described previously.[28](#myc13064-bib-0028){ref-type="ref"}

2.4. Microsatellite typing {#myc13064-sec-0011}
--------------------------

Genotyping of *A fumigatus* isolates was performed with a panel of nine short tandem repeats (STRs) loci (namely STR*Af* 2A, 2B, 2C, 3A, 3B, 3C, 4A, 4B and 4C), as previously described.[29](#myc13064-bib-0029){ref-type="ref"}

Genetic relatedness between the environmental Iranian azole‐resistant TR~46~/Y121F/T289A isolates was compared with already barcoded clinical and environmental isolates from different countries (The Netherlands, India, Tanzania, France, Colombia, Ireland, China and Germany) using BioNumerics software version 7.6.1.(Applied Maths NV).

3. RESULTS {#myc13064-sec-0012}
==========

A total of 63 samples from both Mazandaran (n = 44) and Tehran province (n = 19) yielded *A fumigatus* on SDA supplemented with itraconazole and voriconazole. A total of 57 *A fumigatus* isolates had high MICs level of itraconazole (\>8 mg/L) (55/57) or voriconazole (\>2 mg/L) (51/57) by in vitro antifungal susceptibility testing. Exploring the mechanisms of resistance by mixed‐format real‐time PCR and sequencing of *cyp51A* and its promoter in these isolates showed that resistant isolates had different resistance mechanisms including forty‐four with TR~34~/L98H and three isolates with TR~46~/Y121F/T289A (1 isolate with TR~46~/Y121F/M172I/T289A/G448S and two isolates with TR~46~/Y121F/T289A mutations in the cyp51 region). All three isolates with TR~46~/Y121F/T289A mutation in *cyp51A* and high voriconazole MIC (≥16 mg/L) were isolated from Mazandaran province. Microsatellite analysis revealed two different genotypes among isolates harbouring TR~46~/Y121F/T289A. Two strains had the same alleles across all nine examined microsatellite loci and the other differed by seven loci (2C, 3A, 3B, 3C, 4A, 4B and 4C). For comparison of the genotype of these isolates with other isolates from different countries, a minimum‐spanning tree was constructed based on nine STR*Af* loci of different azole‐resistant isolates.[29](#myc13064-bib-0029){ref-type="ref"} Two Iranian *A fumigatus* TR~46~/Y121F/T289A isolates were related to resistant isolates originating from India while the third was genetically different from other strains (Figure [1](#myc13064-fig-0001){ref-type="fig"}).

![Minimum‐spanning tree showing the genetic relationship of *A fumigatus* genotypes harbouring TR~46~/Y121F/T289A mutation in cyp51A allele. Genotypic relationship of three Iranian isolates is illustrated by arrows](MYC-63-430-g001){#myc13064-fig-0001}

4. DISCUSSION {#myc13064-sec-0013}
=============

Azole resistance in *A fumigatus* due to TR~34~/L98H and more recent TR~46~/Y121F/T289A mutations in *cyp*51A has been described from wide geographical areas among both clinical and environmental isolates.[30](#myc13064-bib-0030){ref-type="ref"}, [31](#myc13064-bib-0031){ref-type="ref"} This is linked to the widespread use of azole fungicides in agriculture rather than the clinical use of antifungal drugs.[2](#myc13064-bib-0002){ref-type="ref"}, [3](#myc13064-bib-0003){ref-type="ref"}, [4](#myc13064-bib-0004){ref-type="ref"}, [5](#myc13064-bib-0005){ref-type="ref"}, [6](#myc13064-bib-0006){ref-type="ref"}, [7](#myc13064-bib-0007){ref-type="ref"}, [8](#myc13064-bib-0008){ref-type="ref"}, [9](#myc13064-bib-0009){ref-type="ref"}, [10](#myc13064-bib-0010){ref-type="ref"}, [11](#myc13064-bib-0011){ref-type="ref"}, [12](#myc13064-bib-0012){ref-type="ref"}, [13](#myc13064-bib-0013){ref-type="ref"}, [14](#myc13064-bib-0014){ref-type="ref"}, [19](#myc13064-bib-0019){ref-type="ref"}, [20](#myc13064-bib-0020){ref-type="ref"}, [21](#myc13064-bib-0021){ref-type="ref"} The fungicide‐driven mutation TR~46~/Y121F/T289A has been first detected in the Netherlands in 2009.[32](#myc13064-bib-0032){ref-type="ref"} Since then, several reports have demonstrated that, particularly this mutation, corresponded to voriconazole resistance in *A fumigatus* in European, African, American and Asian countries. We report the presence of TR~46~/Y121F/T289A now also from Iran, where until now only TR~34~/L98H had been isolated.[24](#myc13064-bib-0024){ref-type="ref"}, [33](#myc13064-bib-0033){ref-type="ref"}, [34](#myc13064-bib-0034){ref-type="ref"}, [35](#myc13064-bib-0035){ref-type="ref"} This mutation, conferring voriconazole resistance, has been reported from both environmental (China,[17](#myc13064-bib-0017){ref-type="ref"}, [21](#myc13064-bib-0021){ref-type="ref"} Taiwan,[13](#myc13064-bib-0013){ref-type="ref"} United Kingdom,[11](#myc13064-bib-0011){ref-type="ref"} Colombia,[12](#myc13064-bib-0012){ref-type="ref"}, [14](#myc13064-bib-0014){ref-type="ref"} France,[16](#myc13064-bib-0016){ref-type="ref"}, [36](#myc13064-bib-0036){ref-type="ref"} Germany,[37](#myc13064-bib-0037){ref-type="ref"} India,[19](#myc13064-bib-0019){ref-type="ref"} the Netherlands[32](#myc13064-bib-0032){ref-type="ref"} and Tanzania[18](#myc13064-bib-0018){ref-type="ref"}) and clinical sources (Spain,[38](#myc13064-bib-0038){ref-type="ref"}, [39](#myc13064-bib-0039){ref-type="ref"} United Kingdom,[40](#myc13064-bib-0040){ref-type="ref"} France,[41](#myc13064-bib-0041){ref-type="ref"} Portugal,[42](#myc13064-bib-0042){ref-type="ref"}, [43](#myc13064-bib-0043){ref-type="ref"} Argentina,[44](#myc13064-bib-0044){ref-type="ref"} Taiwan,[45](#myc13064-bib-0045){ref-type="ref"} Germany,[46](#myc13064-bib-0046){ref-type="ref"}, [47](#myc13064-bib-0047){ref-type="ref"}, [48](#myc13064-bib-0048){ref-type="ref"}, [49](#myc13064-bib-0049){ref-type="ref"} China,[50](#myc13064-bib-0050){ref-type="ref"}, [51](#myc13064-bib-0051){ref-type="ref"} Japan,[52](#myc13064-bib-0052){ref-type="ref"} United States,[53](#myc13064-bib-0053){ref-type="ref"}, [54](#myc13064-bib-0054){ref-type="ref"} Denmark,[10](#myc13064-bib-0010){ref-type="ref"} Belgium [7](#myc13064-bib-0007){ref-type="ref"}, [55](#myc13064-bib-0055){ref-type="ref"}, [56](#myc13064-bib-0056){ref-type="ref"}, [57](#myc13064-bib-0057){ref-type="ref"} and the Netherlands[7](#myc13064-bib-0007){ref-type="ref"}, [32](#myc13064-bib-0032){ref-type="ref"}, [58](#myc13064-bib-0058){ref-type="ref"}, [59](#myc13064-bib-0059){ref-type="ref"}, [60](#myc13064-bib-0060){ref-type="ref"}) (Table [1](#myc13064-tbl-0001){ref-type="table"}). All previous studies conducted in Iran for monitoring the mechanism of resistance among azole‐resistant *A* *fumigatus* in both clinical and environmental samples showed that the TR~34~/L98H mutation was reported with increasing frequency from 3.3% in 2013 to 6.6% in 2016.[24](#myc13064-bib-0024){ref-type="ref"}, [34](#myc13064-bib-0034){ref-type="ref"} Microsatellite typing of the current isolates showed that two *A fumigatus* isolates with TR~46~/Y121F/T289A isolates were related to resistant isolates from India in 2014. It is noteworthy that the first isolates with TR~34~/L98H in Iran in 2013 were also genotypically related to some resistant clinical and environmental TR~34~/L98H isolates from India and the Netherlands.[24](#myc13064-bib-0024){ref-type="ref"} It is anticipated that strains with the TR~46~/Y121F/T289A or TR~34~/L98H mutation will spread rapidly to other geographical regions especially due to the use of azole‐based agricultural fungicides which is a significant factor in the increase of multiple‐triazole‐resistant *A fumigatus*.[4](#myc13064-bib-0004){ref-type="ref"} In our study, most of the azole‐resistant *A fumigatus* isolated from Iranian compost were from Mazandaran province located in Northern Iran where agricultural activity and subsequently the usage of fungicides are generally higher than in other regions of Iran. Compost is a main ecological niche for *A fumigatus*, and azole residues have been reported to be present in commercial compost.[20](#myc13064-bib-0020){ref-type="ref"} Snelders et al[61](#myc13064-bib-0061){ref-type="ref"} showed that 86% of triazole‐resistant *A fumigatus* isolates recovered from environmental sources such as compost had the same resistance mechanism as found in clinical isolates. Compost is used widely in gardens and indoor plants in Iran, and has a key role in the exposure of azole‐resistant *A fumigatus* to susceptible hosts. Although CLSI and EUCAST have published standardised antifungal susceptibility testing methods to determine the in vitro efficacy of antifungal drugs, most clinical microbiology laboratories in Iran do not routinely perform antifungal susceptibility testing of *Aspergillus* isolates as recommended by ESCMID guidelines.[62](#myc13064-bib-0062){ref-type="ref"} Therefore, the true prevalence of resistance and mechanism of resistance in clinical *A fumigatus* isolates in Iran is unknown. Reports of clinical isolates harbouring this mutation are mainly limited to developed countries in Europe, East Asia and the USA, maybe because of the lack of routine antifungal susceptibility testing in less developed countries (Table [1](#myc13064-tbl-0001){ref-type="table"}). With this background in mind, the emergence of a new azole resistance mechanism in *A fumigatus* isolated from environmental sources in Iran is concerning as this mechanism has been associated with therapeutic failure with voriconazole, the first‐line treatment for invasive aspergillosis. Nevertheless, correlations between in vitro susceptibility results and clinical outcomes are not really estimated for *A fumigatus*. Compost used for planting surroundings of immunocompromised patient\'s houses could be a source of invasive aspergillosis due to azole‐resistant *A fumigatus.* [21](#myc13064-bib-0021){ref-type="ref"}, [22](#myc13064-bib-0022){ref-type="ref"} Our study reinforces the importance of surveillance studies to monitor antifungal susceptibility of clinical isolates in Iran.

###### 

Reports of azole resistant *Aspergillus fumigatus* isolates carrying TR~46~/Y121F/T289A mutation

  Number           Country                 Year of publishing                             Number of environmental isolates   Number of clinical isolates
  ---------------- ----------------------- ---------------------------------------------- ---------------------------------- -----------------------------
  Present report   Iran                    2020                                           3                                  --
  1                China                   2020[21](#myc13064-bib-0021){ref-type="ref"}   6                                  --
  2                Taiwan                  2019[13](#myc13064-bib-0013){ref-type="ref"}   3                                  --
  3                Spain                   2019[38](#myc13064-bib-0038){ref-type="ref"}   --                                 1
  4                Belgium ‐ Netherlands   2019[7](#myc13064-bib-0007){ref-type="ref"}    --                                 12
  5                United kingdom          2019[11](#myc13064-bib-0011){ref-type="ref"}   6                                  --
  6                France                  2019[41](#myc13064-bib-0041){ref-type="ref"}   --                                 2
  7                Colombia                2019[14](#myc13064-bib-0014){ref-type="ref"}   8                                  --
  8                Netherlands             2018[58](#myc13064-bib-0058){ref-type="ref"}   --                                 5
  9                France                  2018[16](#myc13064-bib-0016){ref-type="ref"}   9                                  --
  10               Portugal                2018[42](#myc13064-bib-0042){ref-type="ref"}   --                                 1
  11               Argentina               2018[44](#myc13064-bib-0044){ref-type="ref"}   --                                 1
  12               Taiwan                  2018[45](#myc13064-bib-0045){ref-type="ref"}   --                                 3
  13               Portugal                2018[43](#myc13064-bib-0043){ref-type="ref"}   --                                 1
  14               Germany                 2018[46](#myc13064-bib-0046){ref-type="ref"}   --                                 1
  15               Germany                 2017[47](#myc13064-bib-0047){ref-type="ref"}   --                                 1
  16               Belgium                 2017[55](#myc13064-bib-0055){ref-type="ref"}   --                                 4
  17               Colombia                2017[12](#myc13064-bib-0012){ref-type="ref"}   17                                 --
  18               United kingdom          2017[40](#myc13064-bib-0040){ref-type="ref"}   --                                 1
  19               France                  2017[36](#myc13064-bib-0036){ref-type="ref"}   21                                 1
  20               China                   2016[17](#myc13064-bib-0017){ref-type="ref"}   2                                  --
  21               Netherlands             2016[59](#myc13064-bib-0059){ref-type="ref"}   --                                 4
  22               Japan                   2016[52](#myc13064-bib-0052){ref-type="ref"}   --                                 1
  23               China                   2016[50](#myc13064-bib-0050){ref-type="ref"}   --                                 1
  24               United States           2016[53](#myc13064-bib-0053){ref-type="ref"}   --                                 2
  25               United States           2015[54](#myc13064-bib-0054){ref-type="ref"}   --                                 1
  26               China                   2015[51](#myc13064-bib-0051){ref-type="ref"}   --                                 1
  27               Spain                   2015[39](#myc13064-bib-0039){ref-type="ref"}   --                                 1
  28               Germany                 2015[37](#myc13064-bib-0037){ref-type="ref"}   6                                  --
  29               France                  2015[41](#myc13064-bib-0041){ref-type="ref"}   --                                 2
  30               Germany                 2015[48](#myc13064-bib-0048){ref-type="ref"}   --                                 2
  31               Netherlands             2015[60](#myc13064-bib-0060){ref-type="ref"}   --                                 1
  32               Belgium                 2014[56](#myc13064-bib-0056){ref-type="ref"}   --                                 1
  33               Denmark                 2014[10](#myc13064-bib-0010){ref-type="ref"}   --                                 1
  34               Germany                 2014[49](#myc13064-bib-0049){ref-type="ref"}   --                                 1
  35               Tanzania                2014[18](#myc13064-bib-0018){ref-type="ref"}   4                                  --
  36               India                   2014[19](#myc13064-bib-0019){ref-type="ref"}   6                                  --
  37               Netherlands             2013[32](#myc13064-bib-0032){ref-type="ref"}   14                                 21
  38               Belgium                 2012[57](#myc13064-bib-0057){ref-type="ref"}   --                                 1
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